Hints and tips:
Related Special Reports
...David Moore, vice-president for corporate development, added that the company would focus on acquisitions in diabetes and obesity, ideally in the early stage of development....
...Eli Lilly chief executive David Ricks described the acquisition as “unusual” on Tuesday and called for competition authorities to look into the deal....
...David Ricks, Eli Lilly’s chief executive, said under a draft plan to cut market exclusivity protection from 10 to eight years, it might not be worth the industry pursuing treatments for chronic diseases...
...David Ricks, the chief executive of the Indiana-based drugmaker, said Novo Nordisk’s acquisition of three manufacturing plants was “unusual” given “a growing concern about control of critical nodes in the...
...The trial results on exenatide so far suggested it could be even more beneficial than lixisenatide, said Prof David Dexter, director of research at the charity Parkinson’s UK....
...David Risinger, a Leerink analyst, said in a note on Wednesday that the company had designed its pricing to encourage coverage in employers’ health insurance plans....
...Back in July 2016 when David Ricks was named successor to then chief executive John Lechleiter it was rebuilding after a plunge in revenues caused by the expiry of patents on several top-selling drugs....
...Lilly’s chief executive David Ricks told CNBC he expected full approval of donanemab by the end of the year and it would be priced at a similar range as other Alzheimer’s treatments....
...Q4, Thomson Reuters Q3, Toyota Q2 Thursday UK, Bank of England announces its interest rate decision Results: Apple Q4, Bombardier Q3, BT Group H1, Cloudflare Q3, Coinbase Global Q3, Dropbox Q3, Eli Lilly...
...Here’s what else I’m keeping tabs on today: Results: Eli Lilly, the maker of weight loss drug Mounjaro, reports this morning alongside KKR, Spotify, GE Healthcare and Hertz....
...Today, Eli Lilly is heeding my call. Others should follow,” he wrote on Twitter....
...Its non-tech winners included Apollo Global, Eli Lilly, Airbus and online gambling company Flutter....
...Additional help from Saffeya Ahmed, Monica Lopez, Katie McMurran, Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT’s executive producer....
...Within the past year, two antibody-based drugs, donanemab from Eli Lilly and lecanemab from Biogen and Eisai, have proven in clinical trials to slow memory loss and cognitive decline in Alzheimer’s disease...
...Novo and Lilly have said patient safety is their top priority....
...He presented a PowerPoint containing baby pictures of the firm’s three billionaire co-founders, David Rubenstein, William Conway and Daniel D’Aniello....
...Additional help by Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT’s executive producer. The FT’s global head of audio is Cheryl Brumley....
...Results: Apple, Eli Lilly, ConocoPhillips, Fox, Starbucks, S&P Global, Moderna, Shopify and Paramount Global will report before the market opens....
...Eli Lilly’s chief executive David Ricks told investors in June that the company had axed three drugs in nine months due to the IRA....
...David Ricks, Lilly’s chief executive, told the Financial Times some staff had asked to relocate outside the state even though an Indiana judge has temporarily halted the proposed ban....
...We had help this week from Saffeya Ahmed, David da Silva, Michael Lello, Peter Barber and Gavin Kallmann. Our executive producer is Topher Forhecz....
...Exclusive: Goldman Sachs chief executive David Solomon has decided to stop DJ-ing at high-profile events following criticism that his hobby created a distraction from his work leading the Wall Street firm...
...Drugmakers Eisai and Eli Lilly presented research that shows the benefits to patients from using pioneering new Alzheimer’s drugs very early in the development of the disease....
...Eli Lilly as well, one of their longtime rivals, is the only other company that’s kind of level pegging in obesity has also been developing these internally....
...Eli Lilly’s chief executive David Ricks last year warned that a growing climate of “anti-intellectualism” was hampering the global response to Covid, and questioned whether policymakers were capable of preparing...
International Edition